Clinical Research Directory
Browse clinical research sites, groups, and studies.
PROMETHEE: A Shared Interregional Tele-Tobacco Cessation Platform Embedded Within the IMPULSION Lung Cancer Screening Program
Sponsor: Hospices Civils de Lyon
Summary
This prospective observational study aims to evaluate whether an intensive tele-tobacco cessation program delivered through the PROMETHEE platform improves smoking cessation among smokers participating in the French national lung cancer screening pilot program IMPULSION. Participants receiving the PROMETHEE pathway will be compared with matched controls receiving standard smoking cessation support available through IMPULSION. The primary endpoint is self-reported smoking cessation at 12 months.
Official title: Evaluation of an Intensive Tele-Tobacco Cessation Program Compared With Standard Smoking Cessation Support in Participants of the French IMPULSION Lung Cancer Screening Program (PROMETHEE)
Key Details
Gender
All
Age Range
50 Years - 74 Years
Study Type
OBSERVATIONAL
Enrollment
5400
Start Date
2027-01
Completion Date
2030-01
Last Updated
2026-11-06
Healthy Volunteers
Not specified
Conditions
Interventions
PROMETHEE Cohort
PROMETHEE tele-tobacco platform
Control Cohort
Routine IMPULSION Cohorte
Locations (1)
Service de Pneumologie Aigue Spécialisée et Cancérologie Thoracique, Hôpital Lyon Sud, Hospices Civils de Lyon
Pierre-Bénite, France